Transplantation

NCT00906204
Study Type: Interventional
Study Design: Allocation: Randomized
End point Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator)
Primary Purpose: Treatment

Official Title:
Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Trial to Assess Safety of Single Dose versus Traditional Administration of Thymoglobulin Induction for Renal Transplantation

Ages Eligible for Study: 18 to 65 years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Sponsors and Collaborators
Wright State University
Sanofi
University of Arizona
Wake Forest School of Medicine
University of Nebraska
Methodist Hospital Research Institute, Houston, Texas

Contact: R. Brian Stevens, MD, PhD 937-208-4735 rbstevens@mvh.org
Contact: Theodore Rigley, CTBS 937-208-3842 thrigley@mvh.org